AMP-activated protein kinase: the guardian of cardiac energy status
D. Grahame Hardie
Research Article — Peer-Reviewed Source
Original research published by Hardie et al. in Journal of Clinical Investigation. Redistributed under Open Access — see publisher for license terms. MedTech Research Group provides these references for informational purposes. We do not conduct original research. All studies are the work of their respective authors and institutions.
Several years ago it was proposed that the AMP-activated protein kinase cascade might protect cells against stresses that deplete cellular ATP. Young et al. have now directly tested this by studying the effects of ischemia and reperfusion in perfused hearts from mice expressing a dominant-negative mutant that suppresses the kinase activity in cardiac muscle. Compared with control hearts, the mutant hearts showed clear evidence for increased necrotic damage and increased apoptosis. These findings may have implications for the treatment of ischemic heart disease.
Full text is available at the publisher.
Read at Publisher| DOI | 10.1172/jci22683 |
| Journal | Journal of Clinical Investigation |
| Year | 2004 |
| Authors | D. Grahame Hardie |
| License | Open Access — see publisher for license terms |
| Citations | 91 |